Bank Of America Corp Kronos Bio, Inc. Transaction History
Bank Of America Corp
- $1.21 Trillion
- Q1 2025
A detailed history of Bank Of America Corp transactions in Kronos Bio, Inc. stock. As of the latest transaction made, Bank Of America Corp holds 368 shares of KRON stock, worth $250. This represents 0.0% of its overall portfolio holdings.
Number of Shares
368
Previous 3,222
88.58%
Holding current value
$250
Previous $3,000
100.0%
% of portfolio
0.0%
Previous 0.0%
Shares
15 transactions
Others Institutions Holding KRON
# of Institutions
48Shares Held
19.3MCall Options Held
51.2KPut Options Held
0-
Vida Ventures Advisors, LLC2.77MShares$1.88 Million44.86% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.92MShares$1.31 Million0.0% of portfolio
-
Partners Capital Investment Group, LLP Boston, MA1.45MShares$985,0840.02% of portfolio
-
Alphabet Inc. Mountain View, CA1.44MShares$977,9970.11% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny1.43MShares$969,0440.0% of portfolio
About Kronos Bio, Inc.
- Ticker KRON
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 56,769,100
- Market Cap $38.6M
- Description
- Kronos Bio, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of novel cancer therapeutics. The company's product engine focuses on dysregulated transcription factors and the transcriptional regulatory networks that drive oncogenic activity. Its lead product candidate is entospletinib (ENTO), is an orally...